Eliem Study of ETX-018810 (Oral Drug) for Treatment of Leg and Low Back Pain

Protocol Title: “A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of ETX-018810 in Subjects with Lumbosacral Radicular Pain”

Short Title: Efficacy and Safety of ETX-018810 for the Treatment of Lumbosacral Radicular Pain

Protocol Number: ETX-018810-201
Version: Original (Version 1.0)
Compound: ETX-018810
Study Phase: 2
Sponsor Name: Eliem Therapeutics (UK) Ltd”

Principal Investigator: J. Scott Bainbridge, MD

Sub-investigators: Drew Trainor, DO, Monica Gordon, PA-C

Currently Enrolling

End of content